Trilegal, SAM, Khaitan, Ropes act on India Resurgence Fund ₹992 crore investment in Panacea Biotec

Bar & Bench May 15 2019

India Resurgence Fund, promoted by Piramal Enterprises and Bain Capital Credit, has invested 992 crore in drug firm Panacea Biotec.

This investment is structured by way of non-convertible debentures (NCDs) of up to 864 crore and subscription amount of 32 crore towards share warrants to be allotted on a preferential basis, reported Mint.

Trilegal and Ropes & Gray acted for the investors.

Trilegal Partner Counsel Associates
Corporate  

 

 

Nishant Parikh, Anirudh Agarwala, Arjun Ghose, Kunaal Shah

 

Sneha Vardhan, Tejas Adiga

Senior Associates: Anshul Gosavi, Samira Lalani, Aakriti Shakdher, Sneha Agnihotri, Deep Choudhuri, Rahil Pereira

Associates: Kartik Adhlakha, Snigdha Guha Roy, Srirang Sapre, Deepan Shah, Payal Desai, Ritwik Dash, Akshaya Venkataraman, Gazzal Bishnoi, Vaibhavi Shaunak, Maitreya Shaunak, Nayan Jain, Vruiti Patel, Vaishali Movva

Shardul Amarchand Mangaldas & Co advised Panacea Biotec

Sam & Co Partner Associates
Corporate Abhinav Bhalaik Principal Associate: Daryush Marfatia, Senior Associates: Neekesh Shetty, Gaurav Dugar,

Associates: Chirag Shah, Purva Phadke, Tanay Khanna, Harshvardhan Sunder and Gauri Pathak.

Due Diligence Abhinav Bhalaik

Mukul Baveja

Senior Associates:
Asmita Kerkar, Neekesh ShettyAssociates: Tanvee
Vasudevan, Devika Menon, Avni Merchant, Purva Phadke, Shradha Nigam
Banking & Finance Sapan Gupta

Soummo Biswas

Senior Associate: G. Meenakshi

Associate: Swati Lal

Khaitan & Co acted for one of the promoters of the company.

 

Bar & Bench is available on WhatsApp. For real-time updates on stories, click here to subscribe to our WhatsApp.